Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Trends in Cardiovascular Medicine|July 29, 2017
Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillationBenjamin A Steinberg, Jeffrey B WashamAdvances in Chronic Kidney Disease|September 23, 2008
Risks and benefits of antiplatelet therapy in uremic patientsJeffrey B Washam, George L AdamsJournal of Thrombosis and Thrombolysis|October 27, 2015
Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?Jeffrey B Washam, Jonathan P PicciniCurrent Cardiology Reports|September 14, 2018
Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?Jeffrey B Washam, Manesh R PatelJournal of Thrombosis and Thrombolysis|January 25, 2012
Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopeniaJames W Wisler, Jeffrey B Washam, Richard C BeckerNeurosurgery Clinics of North America|September 19, 2018
Anticoagulants: Pharmacokinetics, Mechanisms of Action, and IndicationsTracy A DeWald, Jeffrey B Washam, Richard C BeckerCardiology Journal|July 25, 2012
QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literatureDonald R Lynch, Jeffrey B Washam, L Kristin NewbyEuropean Heart Journal|June 5, 2024
When cardiovascular medicines should be discontinuedKonstantin A Krychtiuk, Bernard J Gersh, Jeffrey B Washam, et al.The American Journal of Cardiology|April 12, 2005
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromesTrip J Meine, Manesh R Patel, Jeffrey B Washam, et al.Journal of the American Heart Association|October 31, 2015
Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic ReviewMatthew W Sherwood, Chiara Melloni, W Schuyler Jones, et al.Pageof 5